The potency of the broad spectrum bacteriocin, bactofencin A, against staphylococci is highly dependent on primary structure, N-terminal charge and disulphide formation
Abstract Bactofencin A is a novel class IId bacteriocin, produced by the intestinal isolate Lactobacillus salivarius DPC6502, which has potent activity against medically significant pathogens including Staphylococcus aureus. This bacteriocin is unusual in that it has a highly cationic N terminus and...
Saved in:
Main Authors: | Paula M. O’ Connor, Eileen F. O’ Shea, Paul D. Cotter, Colin Hill, R. Paul Ross |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2018
|
Subjects: | |
Online Access: | https://doaj.org/article/c88d2e5ef0df477290231ea0360b64e8 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bactofencin A, a New Type of Cationic Bacteriocin with Unusual Immunity
by: Eileen F. O'Shea, et al.
Published: (2013) -
Controlled functional expression of the bacteriocins pediocin PA-1 and bactofencin A in Escherichia coli
by: Beatriz Mesa-Pereira, et al.
Published: (2017) -
The Non-Lantibiotic Bacteriocin Garvicin Q Targets Man-PTS in a Broad Spectrum of Sensitive Bacterial Genera
by: Aleksandra Tymoszewska, et al.
Published: (2017) -
Bee venom-derived antimicrobial peptide melectin has broad-spectrum potency, cell selectivity, and salt-resistant properties
by: Su Jin Ko, et al.
Published: (2020) -
Bacteriocin Gene-Trait matching across the complete Lactobacillus Pan-genome
by: Fergus W. J. Collins, et al.
Published: (2017)